other material
confidence high
sentiment neutral
materiality 0.55
MAIA Biotechnology enters $7M ATM equity facility with ThinkEquity LLC
MAIA Biotechnology, Inc.
- MAIA may sell up to $7,000,000 of common stock at market prices through ThinkEquity as sales agent.
- Fixed commission rate of 3.0% of gross proceeds; agent also receives expense reimbursement up to $50,000 upfront.
- Sales are subject to a placement notice process and can be suspended by either party on 10 days' notice.
- Agreement filed as Exhibit 10.1; shares offered pursuant to effective S-3 shelf registration statement.
- No obligation to sell; proceeds expected for general corporate purposes per prospectus supplement.